Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - aprepitant, quantity: 40 mg - capsule, hard - excipient ingredients: iron oxide yellow; hypromellose; poloxamer; sucrose; gelatin; sodium lauryl sulfate; titanium dioxide; microcrystalline cellulose; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of:,? highly emetogenic cancer chemotherapy.,? moderately emetogenic cancer chemotherapy,aprepitant is indicated for the prevention of postoperative nausea and vomiting.

Israel - English - Ministry of Health

merck serono ltd - cetuximab - solution for infusion - cetuximab 5 mg/ml - cetuximab - cetuximab - erbitux® is indicated for the treatment of patients with epidermal growth factor receptor (egfr) - expressing, ras wild-type metastatic colorectal cancer• in combination with irinotecan-based chemotherapy• in first-line in combination with folfox• as a single agent in patients who have failed oxaliplatin- and irinotecan-based therapy and who are intolerant to irinotecanerbitux is indicated for the treatment of patients with squamous cell cancer of the head and neck (scchn)• in combination with radiation therapy for locally advanced disease• in combination with platinum-based chemotherapy for recurrent and/or metastatic disease• as a single agent after failure of platinum-based chemotherapy for recurrent and/or metastatic disease

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

eastman chemical australia pty ltd - metham present as the potassium salt - soluble concentrate - metham present as the potassium salt mineral-potassium active 365.0 g/l - mixed function pesticide - bulk potting soil | field application to beds or rows | field application to total area | seedbed | tobacco plant bed | bulk soi - fat hen - seed | fungal diseases - see label | nematode/eelworm | onion weed | prince of wales feather - seed | symphylid | winter grass - seed | amaranthus cruentus | amaranthus powellii | amaranthus viridis | asphodel | club root of crucifers | fusarium | garden centipedes | onion grass | phytophthora | ptilotus exaltus | pythium | rhizoctonia | sclerotinia | seedhead | symphylans | verticillium | wild onion

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

bayer cropscience pty ltd - polyol fat acid esters & p/ethoxylated polyol fat acid; paraffinic petroleum oil - emulsifiable concentrate - polyol fat acid esters & p/ethoxylated polyol fat acid emulsifiers & surfactants active 139.0 g/l; paraffinic petroleum oil petroleum derivative-oil active 715.0 g/l - surfactant - agricultural chemical additive | spray activator | spreading agent | wetting agent - tank mixing | additive | agricultural chemical | herbicide | minimise antagonism | spray tank

Australia - English - Department of Health (Therapeutic Goods Administration)

novachem pty ltd - ct1237 - clinical chemistry trace element ivds - to identify the existence of and quantify particular chemical materials in a clinical specimen.

Australia - English - Department of Health (Therapeutic Goods Administration)

novachem pty ltd - ct833 - clinical chemistry substrate ivds - to identify the existence of and quantify particular chemical materials in a clinical specimen.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aprepitant, quantity: 80 mg - capsule - excipient ingredients: hypromellose; poloxamer; sucrose; microcrystalline cellulose; gelatin; titanium dioxide; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: - highly emetogenic cancer chemotherapy. - moderately emetogenic cancer chemotherapy. aprepitant is indicated for the prevention of postoperative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aprepitant, quantity: 80 mg - capsule - excipient ingredients: hypromellose; poloxamer; sucrose; microcrystalline cellulose; gelatin; sodium lauryl sulfate; titanium dioxide; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: - highly emetogenic cancer chemotherapy. - moderately emetogenic cancer chemotherapy. aprepitant is indicated for the prevention of postoperative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - aprepitant, quantity: 40 mg - capsule - excipient ingredients: hypromellose; poloxamer; sucrose; microcrystalline cellulose; gelatin; sodium lauryl sulfate; titanium dioxide; iron oxide yellow; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid - aprepitant, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: - highly emetogenic cancer chemotherapy. - moderately emetogenic cancer chemotherapy. aprepitant is indicated for the prevention of postoperative nausea and vomiting.

Australia - English - Department of Health (Therapeutic Goods Administration)

astral scientific pty ltd - ct847 - clinical chemistry vitamin and mineral ivds - in-vitro diagnostic test kits and in-vitro diagnostic reagents,controls and calibtrators used for the qualitative and/or quantitative determination of clinical chemistry vitamins and minerals